Breaking News, Promotions & Moves

Selkirk Pharma Appoints Colleen Dixon as CEO

Dixon brings a wealth of knowledge and a client-centric perspective to the company.

Author Image

By: Charlie Sternberg

Associate Editor

Selkirk Pharma Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, has appointed Colleen Dixon as its new Chief Executive Officer. Dixon, who formerly served as Vice President of Program Management at Selkirk Pharma, succeeds Patrick Haffey, the founder of Selkirk Pharma and its Chairman and CEO for the past 6 years. With her extensive background in biopharma R&D, manufacturin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters